Daniela Alberati

1.1k total citations
30 papers, 806 citations indexed

About

Daniela Alberati is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biochemistry. According to data from OpenAlex, Daniela Alberati has authored 30 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 16 papers in Molecular Biology and 10 papers in Biochemistry. Recurrent topics in Daniela Alberati's work include Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (11 papers) and Amino Acid Enzymes and Metabolism (10 papers). Daniela Alberati is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (11 papers) and Amino Acid Enzymes and Metabolism (10 papers). Daniela Alberati collaborates with scholars based in Switzerland, United States and United Kingdom. Daniela Alberati's co-authors include Edilio Borroni, Emmanuel Pinard, Jean‐Luc Moreau, Joseph G. Wettstein, Frédéric Knoflach, Dominik Hainzl, Daniel Umbricht, Meret Martin‐Facklam, Tanya L. Wallace and Ernest Dorflinger and has published in prestigious journals such as NeuroImage, Biological Psychiatry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Daniela Alberati

30 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniela Alberati Switzerland	16	456	358	204	132	121	30	806
Margaret G. Der United States	16	458 1.0×	303 0.8×	80 0.4×	124 0.9×	234 1.9×	26	1.1k
Hugh J. Herdon United Kingdom	20	790 1.7×	692 1.9×	108 0.5×	41 0.3×	129 1.1×	39	1.2k
Karsten K. Madsen Denmark	18	717 1.6×	504 1.4×	122 0.6×	57 0.4×	142 1.2×	21	1.0k
Joseph T. Coyle United States	8	533 1.2×	357 1.0×	211 1.0×	212 1.6×	183 1.5×	9	859
Maryann Burno United States	7	659 1.4×	499 1.4×	104 0.5×	80 0.6×	42 0.3×	7	773
Mark D. Black United States	17	595 1.3×	437 1.2×	46 0.2×	97 0.7×	74 0.6×	28	958
Burbaeva GSh Russia	14	227 0.5×	244 0.7×	99 0.5×	200 1.5×	119 1.0×	83	695
Bruce M. Baron United States	20	413 0.9×	439 1.2×	101 0.5×	68 0.5×	42 0.3×	38	967
Garrick P. Smith Denmark	15	282 0.6×	326 0.9×	70 0.3×	108 0.8×	68 0.6×	23	865
Niufan Gu China	23	271 0.6×	443 1.2×	109 0.5×	149 1.1×	428 3.5×	43	1.1k

Countries citing papers authored by Daniela Alberati

Since Specialization

Citations

This map shows the geographic impact of Daniela Alberati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Alberati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Alberati more than expected).

Fields of papers citing papers by Daniela Alberati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Alberati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Alberati. The network helps show where Daniela Alberati may publish in the future.

Co-authorship network of co-authors of Daniela Alberati

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Alberati. A scholar is included among the top collaborators of Daniela Alberati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Alberati. Daniela Alberati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinard, Emmanuel, et al.. (2018). Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient. CHIMIA International Journal for Chemistry. 72(7-8). 477–477. 25 indexed citations

Yohn, Samantha E., Daniela Alberati, Mercè Correa, & John D. Salamone. (2017). Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions. Psychopharmacology. 234(9-10). 1525–1534. 9 indexed citations

Winter, Michael, Jürgen Funk, Daniela Alberati, et al.. (2016). Effects of GlyT1 inhibition on erythropoiesis and iron homeostasis in rats. Experimental Hematology. 44(10). 964–974.e4. 22 indexed citations

Hofmann, Carsten, Christophe Boetsch, Daniela Alberati, et al.. (2016). Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteers. Psychopharmacology. 233(13). 2429–2439. 21 indexed citations

Goonawardena, Anushka V., Jaime E. Heiss, Courtney Glavis‐Bloom, et al.. (2015). Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism. Neuropsychopharmacology. 41(5). 1319–1328. 9 indexed citations

Umbricht, Daniel, Daniela Alberati, Meret Martin‐Facklam, et al.. (2014). Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia. JAMA Psychiatry. 71(6). 637–637. 186 indexed citations

Parrott, Neil, Dominik Hainzl, Daniela Alberati, et al.. (2013). Physiologically Based Pharmacokinetic Modelling to Predict Single- and Multiple-Dose Human Pharmacokinetics of Bitopertin. Clinical Pharmacokinetics. 52(8). 673–683. 15 indexed citations

Alberati, Daniela, Jean‐Luc Moreau, Judith A. Lengyel, et al.. (2011). Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia. Neuropharmacology. 62(2). 1152–1161. 108 indexed citations

Borroni, Edilio, Yun Zhou, Susanne Ostrowitzki, et al.. (2011). Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography. NeuroImage. 75. 291–300. 14 indexed citations

10.

Dhonnchadha, Bríd Á. Nic, Emmanuel Pinard, Daniela Alberati, et al.. (2011). Inhibiting glycine transporter-1 facilitates cocaine–cue extinction and attenuates reacquisition of cocaine-seeking behavior. Drug and Alcohol Dependence. 122(1-2). 119–126. 15 indexed citations

11.

Alberati, Daniela, Jean‐Luc Moreau, Roland Mory, Emmanuel Pinard, & Joseph G. Wettstein. (2010). Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential. Pharmacology Biochemistry and Behavior. 97(2). 185–191. 15 indexed citations

12.

Pinard, Emmanuel, Daniela Alberati, Edilio Borroni, et al.. (2008). Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5134–5139. 18 indexed citations

13.

Alberati, Daniela, Simona Ceccarelli, Synèse Jolidon, et al.. (2006). Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: Achieving selectivity against the μ opioid and nociceptin/orphanin FQ peptide (NOP) receptors. Bioorganic & Medicinal Chemistry Letters. 16(16). 4305–4310. 11 indexed citations

14.

Alberati, Daniela, Dominik Hainzl, Synèse Jolidon, et al.. (2006). 4-Substituted-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with superior pharmacological and pharmacokinetic parameters. Bioorganic & Medicinal Chemistry Letters. 16(16). 4321–4325. 7 indexed citations

15.

Alberati, Daniela, Dominik Hainzl, Synèse Jolidon, et al.. (2006). Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability. Bioorganic & Medicinal Chemistry Letters. 16(16). 4311–4315. 15 indexed citations

16.

Pinard, Emmanuel, Simona Ceccarelli, Henri Stalder, & Daniela Alberati. (2005). Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 349–353. 19 indexed citations

17.

Ceccarelli, Simona, Emmanuel Pinard, Henri Stalder, & Daniela Alberati. (2005). Discovery of N-(2-hydroxy-2-aryl-cyclohexyl) substituted spiropiperidines as GlyT1 antagonists with improved pharmacological profile. Bioorganic & Medicinal Chemistry Letters. 16(2). 354–357. 19 indexed citations

18.

Pauly-Evers, Meike, Cornelia Schwerdel, Horst Bluethmann, et al.. (2004). Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neuroscience Letters. 373(1). 79–84. 73 indexed citations

19.

Pen, Gwenaëlle Le, et al.. (2003). Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal–lesioned rats: reversal by glycine and a glycine transporter inhibitor. Biological Psychiatry. 54(11). 1162–1170. 90 indexed citations

20.

Horváth, Tamás L., Sabrina Diano, Suzanne Miyamoto, et al.. (2003). Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice. International Journal of Obesity. 27(4). 433–442. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact